Title: Pharmacodynamics and pharmacokinetics of AHR-11748, a new antiepileptic agent, in rodents
Abstract: AHR-11748, the desmethyl metabolite of fluzinamide (an effective antiepileptic), was active in preventing maximal seizures in duced in mice or rats by electroshock and threshold seizures induced in mice by Metrazol®, bicuculline, and pictroxin. The compound showed a profile of anticonvulsant activity similar to those of phenobarbital and valproic acid and different from those of phenytoin and ethosuximide. ED50s were less than those of valproic acid, but greater than thode of phenobarbital. Analysis of plasma and whole brain homogenates of mice indicated that AHR-11748 has an apparent terminal half-life (t12, β) of 1.0 h. The brain: plasma ratio of AHR-11748 was 3.4:1 from 0.5 h to 6 h.
Publication Year: 1990
Publication Date: 1990-04-01
Language: en
Type: article
Indexed In: ['crossref', 'pubmed']
Access and Citation
Cited By Count: 6
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot